Schrenk D, Stüven T, Gohl G, Viebahn R, Bock K W
Institute of Toxicology, University of Tübingen, Germany.
Carcinogenesis. 1995 Apr;16(4):943-6. doi: 10.1093/carcin/16.4.943.
Induction of CYP1A and glutathione S-transferase activities with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was studied in human hepatocytes in primary culture to investigate the variability of inducibility and the potency of TCDD. Determining induction of 7-ethoxyresorufin O-deethylase activity, preferentially catalyzed by CYP1A isozymes, we obtained concentration-response diagrams in TCDD-treated hepatocyte cultures from transplant donors and patients undergoing hepatic surgery. At a concentration of 10(-10) M TCDD approximately half-maximal induction of CYP1A was observed. Northern analysis of CYP1A gene expression showed a similar concentration-response relationship. In comparison with rat hepatocytes, human hepatocytes were about 10-fold less sensitive towards the CYP1A-inducing effect of TCDD. No pronounced interindividual differences in the inducing potency of TCDD (concentration which leads to half-maximal induction) were obvious in the six human individuals studied, whereas the efficacy of CYP1A induction was highly variable. In addition, inducibility of glutathione S-transferase (GST) activity also revealed a considerable degree of interindividual variation, i.e. a complete lack of induction in three out of six hepatocyte preparations and a highly variable efficacy of GST induction among responders which was not related to CYP1A inducibility.
在原代培养的人肝细胞中研究了2,3,7,8-四氯二苯并对二恶英(TCDD)对细胞色素P450 1A(CYP1A)和谷胱甘肽S-转移酶活性的诱导作用,以调查诱导性的变异性和TCDD的效力。通过测定主要由CYP1A同工酶催化的7-乙氧基异吩恶唑酮O-脱乙基酶活性的诱导情况,我们在来自移植供体和接受肝脏手术患者的TCDD处理的肝细胞培养物中获得了浓度-反应图。在TCDD浓度为10^(-10) M时,观察到CYP1A约为最大诱导量的一半。对CYP1A基因表达的Northern分析显示了类似的浓度-反应关系。与大鼠肝细胞相比,人肝细胞对TCDD诱导CYP1A的作用敏感性低约10倍。在所研究的六个人中,TCDD的诱导效力(导致最大诱导量一半的浓度)没有明显的个体差异,而CYP1A诱导的效力则高度可变。此外,谷胱甘肽S-转移酶(GST)活性的诱导性也显示出相当程度的个体差异,即六份肝细胞制剂中有三份完全没有诱导作用,而在有反应者中GST诱导的效力变化很大,且与CYP1A诱导性无关。